Skip to content

Evaluate the role of glycated fibrinogen as a biomarker In coronary artery disease among adult population of western Uttar Pradesh

Evaluate the role of glycated fibrinogen as a biomarker In coronary artery disease among adult population of western Uttar Pradesh - Nil

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/12/098539
Enrollment
60
Registered
2025-12-05
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I219- Acute myocardial infarction, unspecified

Interventions

Intervention1: Nil: Nil

Sponsors

Government Institute of Medical Sciences (GIMS)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: CASES 1.Includes Adult population of western Uttar Pradesh. 2.Patients with recently diagnosed Coronary Artery Disease within 5 years, willing to participate in the research study. CONTROL 3. Apparently Healthy Individuals with Age & Sex matched. 4. Willingness to provide informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients with known coagulation disorders: Coagulation abnormalities can independently alter fibrinogen levels, leading to confounding results. 2.Acute and Chronic infections or autoimmune diseases (e.g., rheumatoid arthritis, lupus): These conditions elevate acute-phase reactants like fibrinogen, unrelated to CAD. 3.Patients with a history of recent surgery or trauma (within the last 3 months): infections increase fibrinogen and glycation levels, which could misrepresent the baseline state. 9 4.Chronic liver disease or renal failure: These affect protein metabolism and fibrinogen synthesis/clearance, interfering with accurate assessment. 5.Patients on anticoagulants or anti-inflammatory therapy (e.g., steroids, NSAIDs): These medications alter fibrinogen levels and inflammatory markers. 6. Patients with old myocardial ischaemia more than 5 years of history. 7.Pragnent and Lactating women.

Design outcomes

Primary

MeasureTime frame
1. To measure the Glycated fibrinogen levels in patients with recently diagnosed Coronary Artery Disease within 5 years and apparently healthy individuals. 2. To evaluate the correlation between the Glycated fibrinogen levels in patients with recently diagnosed Coronary Artery Disease within 5 years and apparently healthy individuals.Timepoint: At the time of enrollment only

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDr Aaliya Honey Khan

Government Institute of Medical Sciences(GIMS)

aaliyahkhan745@gmail.com7017795595

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026